記述言語：英語   出版者・発行元：(一社)日本脳神経外科学会  

記述言語：日本語   出版者・発行元：(一社)日本脊髄外科学会  

症例は80歳女性で、急な頭痛と嘔気のため救急搬送された。頭部CTで後頭蓋にくも膜下出血を認め、3D-CTAでは頭蓋内に動脈瘤や動脈解離の所見を認めなかった。脊髄血管造影ではC7椎間孔から脊髄へ向かうradiculomedullary arteryを認め、前脊髄動脈から左側で動静脈シャントを形成し、同部位から逆行性に頭側へ向かうdrainerを認め、feeder上に動脈瘤が形成されていた。左C8椎間孔レベルのradicular arteryは同定できず、頸椎perimedullary動静脈瘻(AVF)もしくはradicular AVFと診断した。day29に直達術で前方アプローチにてシャント離断を行い、術中所見からradicular AVFと診断した。動脈瘤を凝固し、その近位部を離断した時点でシャントが消失したため、シャントポイントには操作を加えずfeeder occlusionの形で硬膜内操作を終えた。術後37日目にリハビリテーション病院へ転院し、その後自宅退院した。術後1年目でシャントや動脈瘤再発を認めていない。

記述言語：英語   出版者・発行元：(一社)日本脳神経外科学会  

症例は94歳女性で、先天性頭蓋顔面異形成であった。1日前から頭痛および嘔吐を呈していた。重度の難聴および視覚障害があり、コミュニケーションは困難であった。CTにて、くも膜下出血、両側頬骨、下顎骨、外耳道の異形成が認められた。CT angiographyにて、頸動脈低形成および頭蓋内動脈に多発性動脈瘤性変化を認めた。前下小脳動脈瘤破裂と診断し、コイル塞栓術を施行した。患者の特異的顔貌はTreacher Collins症候群と一致していた。術前に誤嚥性肺炎を発症しており、術後6日目まで呼吸管理を行った後、抜管した。その後、意識状態の改善は認められず、下顎骨および鼻腔異形成による気道閉塞のため呼吸状態は悪化した。患者の家族は侵襲的蘇生を望まず、術後14日目に死亡した。

記述言語：日本語   出版者・発行元：株式会社医学書院  

DOI： 10.11477/mf.1436204834

PubMed

記述言語：日本語   出版者・発行元：(一社)日本小児神経外科学会  

症例は0生日女児.妊娠27週に前頭骨の変形と後頸部腫瘤を指摘された.32週の胎児Magnetic Resonance Imaging(MRI)で後頸部脳瘤を認め,38週に予定帝王切開で出生した.後頸部に長径4cmの腫瘤を認め,MRIで腫瘤内に頭蓋内から逸脱した組織を認めたことから後頭部脳瘤と診断した.1生日に脳瘤修復術,9生日に髄液漏修復術を施行した.さらに術後3ヵ月後に水頭症に対して脳室-腹腔シャント術を施行した.同胞の姉も脳瘤にて手術歴がある.同胞間脳瘤発症例は少なく,多彩な奇形を呈する本例はまれである.今回,同胞間発症と水頭症併発の2点に着目して考察を加える.(著者抄録)

記述言語：日本語   出版者・発行元：Journal of Neuro-Oncology  

Purpose: Pineal parenchymal tumors of intermediate differentiation (PPTIDs), which were recognized in the 2007 World Health Organization (WHO) classification, are rare, accounting for less than 1% of all central nervous system tumors. This rarity and novelty complicate the diagnosis and treatments of PPTID. We therefore aimed to evaluate the clinicopathological significance of this tumor. Methods: At 11 institutions participating in the Kyushu Neuro-Oncology Study Group, data for patients diagnosed with PPTID were collected. Central pathology review and KBTBD4 mutation analysis were applied to attain the diagnostically accurate cohort. Results: PPTID was officially diagnosed in 28 patients: 11 (39%) with WHO grade 2 and 17 (61%) with WHO grade 3 tumors. Median age was 49 years, and the male:female ratio was 1:2.1. Surgery was attempted in all 28 patients, and gross total resection (GTR) was achieved in 46% (13/28). Adjuvant radiotherapy and chemotherapy were administered to, respectively, 82% (23/28) and 46% (13/28). The 5-year progression-free survival (PFS) and overall survival rates were 64.9% and 70.4% respectively. Female sex (p = 0.018) and GTR (p < 0.01) were found to be independent prognostic factors for PFS and female sex (p = 0.019) was that for OS. Initial and second recurrences were most often leptomeningeal (67% and 100% respectively). 80% (20/25) of patients harbored a KBTBD4 mutation. Conclusions: Female sex and GTR were independent prognostic factors in our patients with PPTID. Leptomeningeal recurrence was observed to be particularly characteristic of this tumor. The rate of KBTBD4 mutation observed in our cohort was acceptable and this could prove the accuracy of our PPTID cohort.

DOI： 10.1007/s11060-023-04310-w

Scopus

PubMed

記述言語：日本語   出版者・発行元：一般社団法人 日本てんかん学会  

<p>脳梁離断術はてんかん性スパズム、強直発作、脱力発作などの転倒する発作で最も有効とされる。今回、非定型欠神発作重積に脳梁離断術が有効だった1例を経験したので報告する。症例は6歳女児。生後Down症候群と診断された。8カ月時にWest症候群を発症した。5歳時から強直発作、ミオクロニー発作、非定型欠神発作などの多彩な発作を認めるようになり、Lennox-Gastaut syndrome spectrumと診断した。6歳0カ月時には最大で1日100回以上の非定型欠神発作が出現して、脳波検査では発作時、発作間欠時脳波ともに全般性変化を呈した。難治に経過し、薬剤治療による欠神発作重積の抑制は困難と判断して6歳1カ月時に脳梁離断術を行った。手術直後から各種発作は消失した。術後の脳波では全般性棘徐波が右前頭部に局在化した。脳梁を介した神経興奮の拡がりが脳梁離断術によって抑制されたことによって、全般発作である非定型欠神発作が抑えられた可能性を考えた。本症例の経験から、特に欠神発作重積が薬剤抵抗性で退行を呈するなどの緊急性を要する症例では、脳梁離断術の適応を積極的に検討すべきと考えた。</p>

DOI： 10.3805/jjes.40.541

Scopus

記述言語：日本語   出版者・発行元：株式会社医学書院  

DOI： 10.11477/mf.1436204720

PubMed

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

脳梁離断術はてんかん性スパズム、強直発作、脱力発作などの転倒する発作で最も有効とされる。今回、非定型欠神発作重積に脳梁離断術が有効だった1例を経験したので報告する。症例は6歳女児。生後Down症候群と診断された。8ヵ月時にWest症候群を発症した。5歳時から強直発作、ミオクロニー発作、非定型欠神発作などの多彩な発作を認めるようになり、Lennox-Gastaut syndrome spectrumと診断した。6歳0ヵ月時には最大で1日100回以上の非定型欠神発作が出現して、脳波検査では発作時、発作間欠時脳波ともに全般性変化を呈した。難治に経過し、薬剤治療による欠神発作重積の抑制は困難と判断して6歳1ヵ月時に脳梁離断術を行った。手術直後から各種発作は消失した。術後の脳波では全般性棘徐波が右前頭部に局在化した。脳梁を介した神経興奮の拡がりが脳梁離断術によって抑制されたことによって、全般発作である非定型欠神発作が抑えられた可能性を考えた。本症例の経験から、特に欠神発作重積が薬剤抵抗性で退行を呈するなどの緊急性を要する症例では、脳梁離断術の適応を積極的に検討すべきと考えた。(著者抄録)

記述言語：日本語   出版者・発行元：一般社団法人 日本小児神経外科学会  

<p>症例は0生日女児．妊娠27週に前頭骨の変形と後頚部腫瘤を指摘された．32週の胎児Magnetic Resonance Imaging（MRI）で後頚部脳瘤を認め，38週に予定帝王切開で出生した．後頚部に長径4 cmの腫瘤を認め，MRIで腫瘤内に頭蓋内から逸脱した組織を認めたことから後頭部脳瘤と診断した．1生日に脳瘤修復術，9生日に髄液漏修復術を施行した．さらに術後3か月後に水頭症に対して脳室-腹腔シャント術を施行した．同胞の姉も脳瘤にて手術歴がある．同胞間脳瘤発症例は少なく，多彩な奇形を呈する本例はまれである．今回，同胞間発症と水頭症併発の2点に着目して考察を加える．</p>

DOI： 10.34544/jspn.48.3_290

記述言語：日本語   出版者・発行元：日本脊髄外科学会  

DOI： 10.2531/spinalsurg.37.278

記述言語：日本語   出版者・発行元：Pathology Research and Practice  

We reported a case of molecularly defined isocitrate dehydrogenase (IDH)-mutant astrocytoma that recurred twice with aggressive behavior and increased anaplastic morphology. Primary and recurrent tumors were analyzed using custom-made DNA-based cancer gene and RNA-based fusion panels for next-generation sequencing (NGS). NGS analyses revealed that recurrent astrocytoma, in addition to IDH1 and tumor protein 53 mutations detected in the primary lesion, harbored cyclin-dependent kinase inhibitor (CDKN) 2 A/B homozygous deletion and neurotrophic tropomyosin receptor kinase 2 (NTRK2) fusion genes that consisted of golgin A1- and cyclin-dependent kinase 5 regulatory subunit associated protein 2-NTRK2 fusions. Anaplasia and necrosis were observed in the recurrent tumors, but not in the primary lesion. Therefore, the integrative diagnosis was primary IDH-mutant astrocytoma grade 2 and recurrent IDH-mutant astrocytoma grade 4 with NTRK2 fusions. This is a worthwhile report describing a case of IDH-mutant astrocytoma that showed genomic evolution during tumor recurrence. Our report suggests that NTRK fusion and CDKN2A/B homozygous deletion promote high-grade transformation and indicate an unfavorable prognosis of IDH-mutant astrocytoma.

DOI： 10.1016/j.prp.2022.154163

Scopus

PubMed

記述言語：英語   出版者・発行元：(一社)日本脳神経外科学会  

日本人患者のびまん性神経膠腫にみられる、分子遺伝学的プロファイルについて調査した。著者等の大学で収集した、びまん性神経膠腫患者303例の腫瘍組織試料を用いて、神経膠腫に特化した遺伝子パネルから、分子遺伝学的プロファイルを解析した。その結果、膠芽腫(GBM)患者185例に最も変異が多く認められた遺伝子は、TERTp遺伝子、TP53遺伝子、PTEN遺伝子、NF1遺伝子とPDGFRA遺伝子であった。また、欠失が最も多く認められた遺伝子は、PTEN遺伝子およびCDKN2A/B及びRB1遺伝子で、増加/増幅が最も多く認められた遺伝子は、EGFR遺伝子とPDGFRA遺伝子およびCDK4遺伝子であった。さらに、グレードIII乏突起膠腫22例のうち3例には、CDKN2A/B遺伝子のホモ接合性欠失が、4例にはARID1A遺伝子変異が検出され、ARID1A遺伝子変異が無増悪生存転帰不良と関連することが示唆された。なお、WHO脳腫瘍分類2021により、グレードII/IIIでIDH野生型星状細胞腫の62.5%が、IDH野生型のGBMに再分類された。本報により、神経膠腫に特化した遺伝子パネルが、WHO脳腫瘍分類2021に準じた分子診断に適用可能であることが確認された。

記述言語：日本語   出版者・発行元：一般社団法人 日本内分泌学会  

DOI： 10.1507/endocrine.98.s.hpt_63

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

50歳代男性。頭痛の精査目的に施行された頭部MRIで鞍上部腫瘍を認められ、当科に紹介された。MRI所見は鞍上部に最大径17mmの腫瘍性病変を認め、腫瘍は視路に接していた。内分泌学的には明らかな異常は認めず、視野検査でも明らかな障害は認めなかった。無症候性ではあるものの、腫瘍が視路に接しており将来的には症候性となることが予想されたことなどから早期の手術介入の方針とし、開頭経鼻同時手術を施行した。腫瘍は赤色調で周囲脳や硬膜との癒着は目立たなかったが、右の視神経との癒着が強固であった。術中所見から右海綿静脈洞内への腫瘍進展が疑われたため、同部位と視神経周囲は愛護的に操作して腫瘍を摘出し、病理組織所見から傍神経節腫と診断した。術後に全身検索を行い、中枢神経単発の非機能性傍神経節腫と最終診断した。右海綿静脈洞周囲の残存腫瘍が緩徐に増大し、摘出術から17ヵ月後にガンマナイフ照射を行った。

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Pituitary  

Purpose: Delayed postoperative hyponatremia (DPH) is a unique complication of transsphenoidal surgery (TSS) in pituitary tumors. Growth hormone (GH) enhances renal sodium reabsorption; however, the association between postoperative GH reduction and DPH in acromegaly is unclear. This study was performed to clarify the incidence of and the predictive factors for DPH in patients with acromegaly who underwent TSS. Methods: Ninety-four patients with active acromegaly were examined retrospectively. During the postoperative course, patients with serum sodium levels ≤ 134 mEq/L were classified into the DPH group. We compared basic clinical characteristics, tumor characteristics, and preoperative and postoperative examination findings between the DPH and non-DPH groups. Results: DPH occurred in 39 patients (41.5%), and the lowest serum sodium levels were generally observed during postoperative days (PODs) 7–9. They needed a 3-day longer hospital stay than those without DPH. The DPH group had lower preoperative body weight and body mass index. In addition, a transient increase in body weight during PODs 5–7 occurred with a transient decrease in urinary volume in the DPH group. Preoperative and postoperative GH and insulin-like growth factor-1 levels did not differ between the two groups. Conclusion: The findings suggested that lower preoperative weight and a postoperative transient gain in body weight are associated with an increased risk of DPH in acromegaly patients undergoing transsphenoidal surgery.

DOI： 10.1007/s11102-022-01288-y

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Surgical Neurology International  

Background: Cerebrospinal fluid (CSF) leakage is a common complication of ventriculoperitoneal shunt (VPS) and has the potential to induce shunt infection. Especially in infants and children, these are serious complications. DuraGen is a collagen matrix dural substitute used to reduce the risk of CSF leakage in various neurosurgeries. We report our VPS procedure with DuraGen for preventing postoperative CSF leakage in patients aged <1 year. Methods: We used DuraGen to prevent postoperative CSF leakage in six VPS surgeries. Antibiotic-impregnated shunt catheters and programmable valves with anti-siphon devices were also used in all cases. DuraGen was placed inside and atop the burr hole. All cases had an initial shunt pressure of 5 cmH2O. Fibrin glue was not used. Results: The patients underwent follow-up for a year after VPS surgery. There was no postoperative subcutaneous CSF collection or leakage after all six VPS surgeries. Furthermore, no postoperative shunt infections or DuraGen-induced adverse events were noted. Conclusion: We speculate that DuraGen has a preventive effect on postoperative CSF leakage in VPS cases aged <1 year.

DOI： 10.25259/SNI_629_2022

Scopus

PubMed

記述言語：日本語   出版者・発行元：Surgical Neurology International  

Background: Solitary fibrous tumor/hemangiopericytomas (SFT/HPCs) are rare mesenchymal tumors of nonmeningothelial origin that comprises <1% of all central nervous system tumors. Case Description: A 45-year-old male presented with sleep apnea (apnea-hypopnea index was 17.1 events/hour) and dysesthesias of the right upper and lower extremities. The magnetic resonance demonstrated a heterogeneous intradural extra-axial C1 mass with syringobulbia and syringomyelia. The right vertebral angiography revealed a hypervascular mass (i.e., intense tumor staining). With the preoperative diagnosis of a spinal hemangioblastoma, the patient underwent tumor removal. However, intraoperative findings demonstrated that the ventral component of the tumor was intramedullary without a dural attachment. Further, the histological diagnosis was consistent with SFT/HPC (HPC phenotype). The postoperative course was uneventful, and the patient’s symptoms and the syrinxes spontaneously regressed. Conclusion: A 45-year-old male presented a rare spinal intradural lesion at C1 appeared to be a spinal hemangioblastoma, but proved to be SFT/HPC (HPC phenotype) with intramedullary invasion.

DOI： 10.25259/SNI_655_2022

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Epilepsy and Behavior  

Objective: To identify the risk factors for psychological distress in electroencephalography (EEG) technicians during the coronavirus disease 2019 (COVID-19) pandemic. Method: In this national-level cross-sectional survey initiated by Japan Young Epilepsy Section (YES-Japan), a questionnaire was administered to 173 technicians engaged in EEG at four clinics specializing in epilepsy care and 20 hospitals accredited as (quasi-) epilepsy centers or epilepsy training facilities in Japan from March 1 to April 30, 2021. We collected data on participants’ profiles, information about work, and psychological distress outcome measurements, such as the K-6 and Tokyo Metropolitan Distress Scale for Pandemic (TMDP). Linear regression analysis was used to identify the risk factors for psychological distress. Factors that were significantly associated with psychological distress in the univariate analysis were subjected to multivariate analysis. Results: Among the 142 respondents (response rate: 82%), 128 were included in the final analysis. As many as 35.2% of EEG technicians have been under psychological distress. In multivariate linear regression analysis for K-6, female sex, examination for patients (suspected) with COVID-19, and change in salary or bonus were independent associated factors for psychological distress. Contrastingly, in multivariate linear regression analysis for TMDP, female sex, presence of cohabitants who had to be separated from the respondent due to this pandemic, and change in salary or bonus were independent associated factors for psychological distress. Conclusion: We successfully identified the risk factors associated with psychological distress in EEG technicians during the COVID-19 pandemic. Our results may help in understanding the psychological stress in EEG technicians during the COVID-19 pandemic and improving the work environment, which is necessary to maintain the mental health of EEG technicians.

DOI： 10.1016/j.yebeh.2021.108361

Web of Science

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Interdisciplinary Neurosurgery: Advanced Techniques and Case Management  

Background: Spinal sagittal malalignment affects a patient's quality of life, and the condition has gained increasing importance. The cranial center of the gravity-sagittal vertical axis (CCG-SVA) helps in assessing sagittal alignment. Two major landmarks of the CCG are used for measuring the CCG-SVA: the midpoint of the nasion-inion line (MNI) and the external auditory canal (EAC). However, the correspondence between these two points has not been proved. In this study, we radiologically examined the positional relationship between them. Methods: We obtained lateral skull radiographs from 87 patients aged between 21 and 91 years. We evaluated the following: the vertical distance between the MNI and the upper margin of the EAC (Distance A), the horizontal distance between the plumb line from the MNI and the anterior margin of the EAC (Distance B), and the horizontal distance between the plumb line from the MNI and the center of the EAC (Distance C). Results: The average values of Distances A, B, and C were 19.6 ± 5.0, 1.65 ± 5.7, and 5.45 ± 5.5 mm, respectively, indicating that the plumb lines dropped from the MNI and the EAC did not match exactly. The measured values showed no sex-specific differences (P > 0.05, Mann–Whitney U test). Conclusions: The present study demonstrated that the MNI and EAC locations had minimal horizontal differences. The CCG-SVA should be measured by considering the differences between the MNI and the EAC.

DOI： 10.1016/j.inat.2021.101299

Web of Science

Scopus

記述言語：英語   出版者・発行元：(一社)日本脳神経外科学会  

症例は13歳男児で、先天性脳性麻痺と精神遅滞があった。過去にウエスト症候群と診断され、副腎皮質刺激ホルモン療法を受けたが、毎日のように体の両側に筋反射や痙攣を伴う薬剤抵抗性のてんかんを発症していた。11歳時に約1分間続く強直発作を呈し、数分おきに数回繰り返された。てんかん重積の診断に基づき、ミダゾラム持続静脈注射(IV-MDZ)や経口薬などで薬物治療が行われ、1分未満の強直発作を1日2〜8回繰り返す散発性けいれん群発(SC)が月に1〜2回発生する状態になった。2年後、持続性SCを呈してミダゾラム持続静脈注射(IV-MDZ)や経口薬などで薬物治療が行われたが改善しなかった。迷走神経刺激(VNS)デバイスを植え込み、VNSを迅速に導入した。IV-MDZを漸減させてもSCが悪化しなかったため、VNS導入4週間後にMDZを中止した。難治性でないSCもVNSの10ヵ月後には消失した。発作の重症度は改善し、頻度は毎日から数ヵ月に1回に減少した。脳波上のてんかん活動も有意に低下した。

記述言語：英語   出版者・発行元：(一社)日本脳神経外科学会  

症例は22歳男性で、頭痛、めまい、失見当識、全般発作を呈していた。小児期からの再発性口内潰瘍および結節性紅斑の既往歴、てんかんの家族歴があった。MRIにて脳橋に病変が認められた。ステロイドパルス療法を行ったところ、症状の改善が認められた。しかし、発症から1年後に再発を認め、神経ベーチェット病(NBD)と診断された。MRI T2強調画像にて、脳幹、小脳、右内側側頭葉、両側基底核に高信号が認められた。また、左海馬の萎縮も認めた。ステロイドおよび免疫抑制剤の投与により、NBDはコントロールされた。しかし、NBD発症から3年後、内側側頭葉てんかんを発症した。薬剤耐性となり、NBD発症から12年後に手術が検討された。術前MRIにて左海馬硬化が認められた。NBD発症から13年後に左側頭葉前部切除術が施行された。術後2年以上、無発作状態が認められた。

記述言語：英語   出版者・発行元：Hiroshima University Medical Press  

<p>Background: Gadolinium-enhanced magnetic resonance imaging (MRI) can be used to observe the progression of cerebral infarction, which sometimes mimics malignant brain tumors. While the β2-microglobulin (β2MG) level in blood plasma or cerebrospinal fluid (CSF) is useful for the diagnosis of malignant tumors or degenerative diseases, these results may create confusion regarding a definitive diagnosis, because it is not a specific marker. We present a rare case of symptomatic developmental venous anomaly (DVA), accompanied by transient, irregular, enhanced cerebral lesions and elevated β2MG in the CSF.</p><p>Case Description: A 56-year-old woman developed dysarthria and underwent MRI, which revealed a right frontal hyperintense area around a previous lesion on diffusion-weighted imaging (DWI). She was treated based on the tentative diagnosis of an ischemic cerebrovascular event, and symptoms subsided in 3 days. MRI on day 7 revealed an enlargement of the hyperintense area on DWI. Post-gadolinium MRI showed multiple, enhanced patchy areas in the right frontal lobe and an abnormally large vein connected to dilated medullary venules, indicating DVA. Magnetic resonance angiography showed no stenosis or arterial occlusion. The β2MG level in the CSF was elevated at 2,061 μg/l, and a differential diagnosis from malignant tumor was required. However, MRI on day 23 revealed total disappearance of the enhanced lesions and a decrease in the high intensity area on DWI. Considering the clinical course, the DVA was symptomatic because of the perfusion disturbance.</p><p>Conclusion: Careful evaluation is necessary when considering the associated pathologies and potential complications of DVA if detected near a gadolinium-enhanced lesion.</p>

DOI： 10.24811/hjms.68.1_13

記述言語：日本語   出版者・発行元：一般社団法人 日本てんかん学会  

DOI： 10.3805/jjes.36.657

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Brain Tumor Pathology  

A prompt and reliable molecular diagnosis for brain tumors has become crucial in precision medicine. While Comprehensive Genomic Profiling (CGP) has become feasible, there remains room for enhancement in brain tumor diagnosis due to the partial lack of essential genes and limitations in broad copy number analysis. In addition, the long turnaround time of commercially available CGPs poses an additional obstacle to the timely implementation of results in clinics. To address these challenges, we developed a CGP encompassing 113 genes, genome-wide copy number changes, and MGMT promoter methylation. Our CGP incorporates not only diagnostic genes but also supplementary genes valuable for research. Our CGP enables us to simultaneous identification of mutations, gene fusions, focal and broad copy number alterations, and MGMT promoter methylation status, with results delivered within a minimum of 4 days. Validation of our CGP, through comparisons with whole-genome sequencing, RNA sequencing, and pyrosequencing, has certified its accuracy and reliability. We applied our CGP for 23 consecutive cases of intracranial mass lesions, which demonstrated its efficacy in aiding diagnosis and prognostication. Our CGP offers a comprehensive and rapid molecular profiling for gliomas, which could potentially apply to clinical practices and research primarily in the field of brain tumors.

DOI： 10.1007/s10014-023-00476-3

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：World Neurosurgery  

Objective: Spondylotic changes in the cervical spine cause degeneration, leading to cervical spinal canal stenosis. This stenotic change can affect cerebrospinal fluid (CSF) dynamics by compressing the dural sac and reducing space in the subarachnoid space. We examined CSF dynamics at the craniovertebral junction (CVJ) using time-spatial labeling inversion pulse magnetic resonance imaging (Time-SLIP MRI) in patients with cervical spinal canal stenosis. Methods: The maximum longitudinal movement of the CSF at the CVJ was measured as length of motion (LOM) in the Time-SLIP MRI of 56 patients. The sum of ventral and dorsal LOM was defined as the total LOM. Patients were classified into 3 groups depending on their spinal sagittal magnetic resonance imaging findings: control (n = 27, Kang classification grades 0 and 1), stenosis (n = 14, Kang classification grade 2), and severe stenosis (n = 15, Kang classification grade 3). Results: Time-SLIP MRI revealed pulsatile movement of the CSF at the CVJ. The mean total, ventral, and dorsal LOM was 14.2 ± 9, 8.1 ± 5.7, and 3.8 ± 2.9 mm, respectively. The ventral LOM was significantly larger than the dorsal LOM. The total LOM was significantly smaller in the severe stenosis group (6.1 ± 3.4 mm) than in the control (16.0 ± 8.4 mm) or stenosis (11 ± 5.4 mm) groups (P < 0.001, Kruskal-Wallis H-test). In 5 patients, postoperative total LOM was improved after adequate decompression surgery. Conclusions: This study demonstrates that CSF dynamics at the CVJ are influenced by cervical spinal canal stenosis. Time-SLIP MRI is useful for evaluating CSF dynamics at the CVJ in patients with spinal canal stenosis.

DOI： 10.1016/j.wneu.2024.02.020

Scopus

PubMed

記述言語：英語   出版者・発行元：Surgical Neurology International  

Background: Although rare, cases of hypophysitis resembling a pituitary abscess (PA) have been reported. Differential diagnosis between hypophysitis and PA is crucial as the two diseases require different treatments. Case Description: A 38-year-old woman with headaches underwent head magnetic resonance imaging (MRI), which revealed an 11-mm mass lesion in the sella turcica. Due to breastfeeding, contrast-enhanced MRI was avoided. Pituitary adenomas and Rathke’s cleft cyst (RCC) were suspected, and she was initially treated conservatively. Five months later, she acquired syndrome coronavirus two infections, and while the fever subsided with acetaminophen, the headache persisted. One month later, the headache worsened, followed by fever and diabetes insipidus. MRI revealed a pituitary cystic mass with ring-shaped contrast enhancement on T1-weighted MRI and increased signal intensity on diffusion-weighted imaging (DWI). PA was suspected, and emergency endoscopic transsphenoidal surgery was performed. The microbiological examination of the yellowish-brown content drained from the cystic mass was negative. Microscopically, the cystic lesion was covered with ciliated columnar epithelium and stratified squamous epithelium, with a dense inflammatory cell infiltrate consisting mainly of lymphocytes and plasma cells observed around the cyst. This supported the diagnosis of secondary hypophysitis associated with RCC without PA. Conclusion: We report a case of hypophysitis secondary to RCC resembling PA with ring-shaped contrast enhancement on MRI and increased signal intensity on DWI. This case emphasizes the need for cautious diagnosis of secondary hypophysitis due to RCC in individuals with MRIs and clinical manifestations resembling an abscess.

DOI： 10.25259/SNI_947_2023

Scopus

PubMed

記述言語：英語   出版者・発行元：一般社団法人 日本脳神経外科学会  

DOI： 10.2176/jns-nmc.2022-0267

PubMed

記述言語：英語   出版者・発行元：一般社団法人 日本脳神経外科学会  

DOI： 10.2176/jns-nmc.2023-0152

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Cancer Imaging  

Background: This study aimed to elucidate the impact of effective diffusion time setting on apparent diffusion coefficient (ADC)-based differentiation between primary central nervous system lymphomas (PCNSLs) and glioblastomas (GBMs) and to investigate the usage of time-dependent diffusion magnetic resonance imaging (MRI) parameters. Methods: A retrospective study was conducted involving 21 patients with PCNSLs and 66 patients with GBMs using diffusion weighted imaging (DWI) sequences with oscillating gradient spin-echo (Δeff = 7.1 ms) and conventional pulsed gradient (Δeff = 44.5 ms). In addition to ADC maps at the two diffusion times (ADC7.1 ms and ADC44.5 ms), we generated maps of the ADC changes (cADC) and the relative ADC changes (rcADC) between the two diffusion times. Regions of interest were placed on enhancing regions and non-enhancing peritumoral regions. The mean and the fifth and 95th percentile values of each parameter were compared between PCNSLs and GBMs. The area under the receiver operating characteristic curve (AUC) values were used to compare the discriminating performances among the indices. Results: In enhancing regions, the mean and fifth and 95th percentile values of ADC44.5 ms and ADC7.1 ms in PCNSLs were significantly lower than those in GBMs (p = 0.02 for 95th percentile of ADC44.5 ms, p = 0.04 for ADC7.1 ms, and p < 0.01 for others). Furthermore, the mean and fifth and 95th percentile values of cADC and rcADC were significantly higher in PCNSLs than in GBMs (each p < 0.01). The AUC of the best-performing index for ADC7.1 ms was significantly lower than that for ADC44.5 ms (p < 0.001). The mean rcADC showed the highest discriminating performance (AUC = 0.920) among all indices. In peritumoral regions, no significant difference in any of the three indices of ADC44.5 ms, ADC7.1 ms, cADC, and rcADC was observed between PCNSLs and GBMs. Conclusions: Effective diffusion time setting can have a crucial impact on the performance of ADC in differentiating between PCNSLs and GBMs. The time-dependent diffusion MRI parameters may be useful in the differentiation of these lesions.

DOI： 10.1186/s40644-023-00639-7

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Neurosurgical Review  

To assess the use of indocyanine green (ICG) fluorescence endoscopy to evaluate pituitary blood flow in craniopharyngioma resection and its possible impact on intraoperative decisions regarding pituitary stalk processing. Patients with craniopharyngiomas who had undergone transsphenoidal surgery since March 2021, when an ICG endoscope was introduced at the Kagoshima University Hospital, were included in the study. When targeted tumor removal was approaching completion, 10 mg of ICG was administered intravenously to evaluate blood flow in the pituitary stalk and gland. ICG signals and endocrinological status before and after surgery were evaluated retrospectively. Pituitary stalk and gland blood flow were evaluated as positive (++), weakly positive (+), and no signal (−).Ten patients with craniopharyngiomas underwent transsphenoidal surgery using an ICG endoscope (mean age 56.6 ± 14.2 years; 40% male). Among the eight patients in whom the pituitary stalk was preserved, pituitary function with positive signal on the stalk was intact in two. Two other patients with weakly positive stalk and positive pituitary gland signals showed intact function or minimal pituitary dysfunction. Four patients had impairments in more than three axes with poor ICG signals in the stalk or pituitary gland. Two patients underwent pituitary amputation because of high tumor invasion and lack of ICG signal in the stalk after tumor removal, resulting in panhypopituitarism. A negative ICG signal in the pituitary stalk is likely to indicate postoperative pituitary function loss. Craniopharyngioma surgery using ICG endoscopy may be useful for predicting endocrine prognosis and improving tumor outcomes.

DOI： 10.1007/s10143-023-02223-w

Scopus

PubMed

記述言語：日本語   出版者・発行元：(一社)日本病理学会  

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Epilepsia Open  

Objective: Perampanel is an oral anti-seizure medication, which is approved in Japan for focal-onset seizures, with/without focal to bilateral tonic–clonic seizures, as monotherapy/adjunctive therapy in patients aged 4 years and older. Treatment for generalized tonic–clonic seizures as adjunctive therapy in patients aged 12 years and older is approved as well. We evaluated the feasibility of intravenous (IV) administration of perampanel as an alternative to oral administration. Methods: Study 240 (NCT03754582) was an uncontrolled, open-label study of IV perampanel, conducted in 21 Japanese patients with epilepsy who received a stable dose of 8–12 mg/day of oral perampanel. Patients received 30-minute IV infusions at equivalent daily doses of oral perampanel for 4 days, then were switched back to oral perampanel. Safety, tolerability, plasma concentration, and maintenance of efficacy throughout the transition between IV and oral dosing of perampanel were assessed. As supportive data, a subgroup analysis was also conducted using data from healthy Japanese subjects (n = 18) who were enrolled in Study 050 (NCT03376997) investigating the pharmacokinetics and safety of IV perampanel in healthy subjects who received an IV infusion (30-, 60-, or 90-minute) of perampanel 12 mg and a single oral administration of perampanel 12-mg tablet. Results: In Study 240, the transition between 30-minute IV and oral perampanel dosing was associated with a ≤1.4-fold increase in the mean change in maximum observed concentration of perampanel. Seizure outcomes demonstrated no considerable changes in efficacy before, during, or after 30-minute IV dosing of perampanel. The safety profiles were similar between IV and oral formulations. In Study 050, the pharmacokinetics of 30- or 60-minute IV infusion of perampanel further support the interchangeability between oral and IV formulations in the Japanese subjects. Significance: These results support that 30-minute IV perampanel may be a potential short-term alternative to oral formulations for patients with epilepsy.

DOI： 10.1002/epi4.12804

Scopus

PubMed

記述言語：英語   出版者・発行元：Pathology Research and Practice  

Amplification of the epidermal growth factor receptor gene (EGFR) and its variants are the most commonly detected pathogenic gene alterations in glioblastoma. Herein, we report a case of molecularly defined glioblastoma harboring an EGFR variant III (EGFRvIII) without EGFR amplification. The initial histological diagnosis was isocitrate dehydrogenase (IDH)-wildtype low-grade glioma, due to an absence of anaplasia, necrosis, and microvascular proliferation, and a low Ki-67 labeling index. DNA-based next-generation sequencing (NGS) panel analysis revealed a TERTp promoter mutation but no EGFR mutation or amplification, supporting the diagnosis of “molecular glioblastoma.” However, RNA-based NGS panel analysis revealed mRNA expression of EGFRvIII. Therefore, the final integrative diagnosis was glioblastoma with non-amplified EGFRvIII. Our report suggests that non-amplified EGFRvIII might be an early molecular event in glioblastoma tumorigenesis. In addition to the usual DNA-based analysis, RNA-based analysis is required to identify exon-skipping EGFR variants without EGFR amplification.

DOI： 10.1016/j.prp.2023.154712

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：株式会社医学書院  

DOI： 10.11477/mf.1436204790

PubMed

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：World Neurosurgery  

Background: There is a large disparity between the quality of neurosurgical research in developed and developing nations, including the Association of Southeast Asian Nations (ASEAN). Bibliometric analysis is an appropriate method for evaluating the quality of research in a geographic region. We analyzed the neurosurgery reports published by the ASEAN countries to highlight regional productivity in neurosurgery research. Methods: We performed a bibliometric analysis of neurosurgery reports from the ASEAN countries between 2011 and 2020. We described the publication number, study type, and field of study of the publication articles. In addition, we assessed the correlations between the neurosurgery research productivity of these countries and the neurosurgeon ratio, medical doctor ratio, per capita gross domestic product, and health expenditure per capita. Results: We identified 1939 neurosurgeons in the ASEAN region; 570 articles were published by neurosurgeons in the region between 2011 and 2020. Singaporean neurosurgeons were the most productive, with 177 articles, accounting for 31% of the total ASEAN neurosurgeon publications in the study period. However, there has been a rapid recent increase in the number of articles. Case reports and tumors were the dominant type and field of the articles, respectively. There was no significant correlation between the neurosurgical research productivity of the ASEAN countries and the neurosurgeon ratio, medical doctor ratio, per capita gross domestic product, and health expenditure per capita. Conclusions: By analyzing the neurosurgery publications from ASEAN countries over the previous decade, we highlight the status of neurosurgical research in these countries.

DOI： 10.1016/j.wneu.2023.01.059

Scopus

PubMed

記述言語：英語   出版者・発行元：International Journal of Surgery Case Reports  

Introduction: Intracranial electroencephalography is a crucial diagnostic technique for epilepsy surgery, though it is associated with a range of complications, including infection, intracranial hemorrhage, increased intracranial pressure, and cerebral infarction. This case study presents an uncommon occurrence of stenosis of the left posterior cerebral artery (PCA) following intracranial electrode implantation. Case presentation: A woman in her thirties with drug-resistant focal impaired awareness seizures underwent implantation of subdural and depth electrodes on the bilateral temporal lobes to lateralize seizure onset. A left anterior-temporal lobectomy was performed based on the evaluation results. Following the resection of the hippocampus, stenosis of the left PCA, with a pinched appearance, was observed. Postoperatively, extensive cerebral edema in the bilateral temporal lobes and a defect in the left PCA were detected on magnetic resonance (MR) imaging. MR imaging performed the day after surgery showed cerebral infarction in the left medial temporal lobe and left lateral thalamus. A video review indicated that surgical manipulation was not the cause of vascular stenosis. MR angiography one week later confirmed the recanalization of the PCA. Discussion: We surmised that the subdural electrodes inserted along the middle skull base might have induced the PCA stenosis or spasms. The patient did not experience any significant sequelae, with no episodes of seizures for more than five years after surgery. Conclusion: It is essential to note that subdural grid electrodes placed in the medial temporal lobe can cause vascular stenosis, albeit with an extremely rare occurrence.

DOI： 10.1016/j.ijscr.2023.107988

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

DOI： 10.1055/s-0043-1763526

PubMed

記述言語：英語   出版者・発行元：International Journal of Surgery Case Reports  

Introduction and importance: Intracranial germinomas are germ cell tumors that commonly develop in the pineal or neurohypophysis regions. As ectopic germinomas are rarely observed within the cerebrum and are associated with atypical image findings, diagnosis is challenging. Case presentation: A 14-year-old boy was admitted to our hospital with complaints of vomiting and headache. Gadolinium-enhanced magnetic resonance imaging revealed ring-enhancing lesions in his left frontal lobe and basal ganglia. Susceptibility-weighted imaging indicated that the subependymal veins passing through the lesion centers were engorged, while electrophoretic analysis of cerebrospinal fluid identified oligoclonal bands (OCBs); both were typical of multiple sclerosis (MS). Tumor biopsy revealed many cells with atypical mitotic figures and nuclear enlargements, suggesting malignant disease. As the tumor rapidly proliferated, we opted for surgical excision of the lesions. Histopathological analyses revealed “two-cell patterns” characteristic of germinoma. Immunohistochemistry was positive for placental alkaline phosphatase and c-KIT. The definitive diagnosis was germinoma. After chemoradiotherapy, the patient was discharged without neurological deficits. Clinical discussion: OCBs and several magnetic resonance imaging features (including open ring enhancement, T2 hypointense rims, mild mass effects, mild perilesional edema, peripheral restriction around the lesion, and vessel-like structures running through the lesion center) are useful diagnostic signs for the radiological discrimination of MS from germinoma. However, owing to these factors, some cases are difficult to diagnose. Conclusion: Our case report of an unusual ectopic cerebral germinoma illustrates the difficulty of distinguishing it from MS. Therefore, we recommend proper tissue sampling in such cases, especially in adolescent patients, to make definitive germinoma diagnoses.

DOI： 10.1016/j.ijscr.2023.107884

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Surgical Neurology International  

Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder presenting a triad including dementia and ventricular enlargement. The mechanism causing excessive cerebrospinal fluid (CSF) accumulation in the ventricles in iNPH is poorly understood. We hypothesized that the age-related degradation of the spinal shock-absorbing system composed of a spinal dural sac (SDS) and surrounding soft tissue, preventing ventricular enlargement caused by wide CSF pulsation driven by heartbeats, may be involved in the ventricular enlargement observed in iNPH. Methods: Sixty-four patients with iNPH in their seventies who underwent a lumboperitoneal shunt and a control group of 79 people in the same age group who underwent brain check-ups were included in the study. We compared the sizes of the cervical and upper parts of the thoracic SDS using magnetic resonance imaging between the two groups. Results: The anterior-posterior distances of the dural sac at C5 were shorter in patients with iNPH of both sexes than those in the control group (P = 0.0008 in men and P = 0.0047 in women). The number of disc levels with disappeared CSF space surrounding the cervical cord was more in iNPH (P = 0.0176 and P = 0.0003). The midsagittal area of the upper part of the spinal sac, C2-Th4, was smaller in iNPH (P = 0.0057 and P = 0.0290). Conclusion: Narrowing of the cervical dural sac and midsagittal area in the upper part of the SDS in patients with iNPH may reflect the degradation of the shock-absorbing mechanism for CSF pressure pulsations, which may cause iNPH or at least aggravate iNPH by other unknown causes.

DOI： 10.25259/SNI_474_2023

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Neuro-Oncology Advances  

Background: Telomerase reverse transcriptase promoter (TERTp) mutations are a biological marker of glioblastoma; however, the prognostic significance of TERTp mutational status is controversial. We evaluated this impact by retrospectively analyzing the outcomes of patients with isocitrate dehydrogenase (IDH)- and TERTp-wild-type glioblastomas. Methods: Using custom next-generation sequencing, we analyzed 208 glioblastoma samples harboring wild-type IDH. Results: TERTp mutations were detected in 143 samples (68.8%). The remaining 65 (31.2%) were TERTp-wild-type. Among the TERTp-wild-type glioblastoma samples, we observed a significant difference in median progression-free survival (18.6 and 11.4 months, respectively) and overall survival (not reached and 15.7 months, respectively) in patients with and without phosphatase and tensin homolog (PTEN) loss and/or mutation. Patients with TERTp-wild-type glioblastomas with PTEN loss and/or mutation were younger and had higher Karnofsky Performance Status scores than those without PTEN loss and/or mutation. We divided the patients with TERTp-wild-type into 3 clusters using unsupervised hierarchical clustering: Good (PTEN and TP53 alterations; lack of CDKN2A/B homozygous deletion and platelet-derived growth factor receptor alpha (PDGFRA) alterations), intermediate (PTEN alterations, CDKN2A/B homozygous deletion, lack of PDGFRA, and TP53 alterations), and poor (PDGFRA and TP53 alterations, CDKN2A/B homozygous deletion, and lack of PTEN alterations) outcomes. Kaplan-Meier survival analysis indicated that these clusters significantly correlated with the overall survival of TERTp-wild-type glioblastoma patients. Conclusions: Here, we report that PTEN loss and/or mutation is the most useful marker for predicting favorable outcomes in patients with IDH- and TERTp-wild-type glioblastomas. The combination of 4 genes, PTEN, TP53, CDKN2A/B, and PDGFRA, is important for the molecular classification and individual prognosis of patients with IDH- and TERTp-wild-type glioblastomas.

DOI： 10.1093/noajnl/vdad078

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Neuro-Oncology Advances  

Background: Glioblastoma (GBM) is a malignant brain tumor, with radiological and genetic heterogeneity. We examined the association between radiological characteristics and driver gene alterations. Methods: We analyzed the driver genes of 124 patients with IDH wild-type GBM with contrast enhancement using magnetic resonance imaging. We used a next-generation sequencing panel to identify mutations in driver genes and matched them with radiological information. Contrast-enhancing lesion localization of GBMs was classified into 4 groups based on their relationship with the subventricular zone (SVZ) and cortex (Ctx). Results: The cohort included 69 men (55.6%) and 55 women (44.4%) with a mean age of 66.4 ± 13.3 years. EGFR and PDGFRA alterations were detected in 28.2% and 22.6% of the patients, respectively. Contrast-enhancing lesion touching both the SVZ and Ctx was excluded because it was difficult to determine whether it originated from the SVZ or Ctx. Contrast-enhancing lesions touching the SVZ but not the Ctx had significantly worse overall survival than non-SVZ lesions (441 days vs. 897 days, P = .002). GBM touching only the Ctx had a better prognosis (901 days vs. 473 days, P < .001) than non-Ctx lesions and was associated with EGFR alteration (39.4% vs. 13.2%, P = .015). Multiple contrast lesions were predominant in PDGFRA alteration and RB1-wild type (P = .036 and P = .031, respectively). Conclusions: EGFR alteration was associated with cortical lesions. And PDGFRA alteration correlated with multiple lesions. Our results suggest that clarifying the association between driver genes and tumor localization may be useful in clinical practice, including prognosis prediction.

DOI： 10.1093/noajnl/vdad110

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：一般社団法人 日本脳神経外科学会  

Rapid technological advances in molecular biology, including next-generation sequencing, have identified key genetic alterations in central nervous system (CNS) tumors. Accordingly, the fifth edition of the World Health Organization (WHO) CNS tumor classification was published in 2021. We analyzed 303 patients with diffuse glioma using an amplicon-based glioma-tailored gene panel for detecting 1p/ 19q codeletion and driver gene mutations such as IDH1/2, TERTp, EGFR, and CDKN2A/B on a single platform. Within glioblastomas (GBMs), the most commonly mutated genes were TERTp, TP53, PTEN, NF1, and PDGFRA, which was the most frequently mutated tyrosine kinase receptor in GBM, followed by EGFR. The genes that most commonly showed evidence of loss were PTEN, CDKN2A/B, and RB1, whereas the genes that most commonly showed evidence of gain/amplification were EGFR, PDGFRA, and CDK4. In 22 grade III oligodendroglial tumors, 3 (14%) patients had CDKN2A/B homozygous dele-tion, and 4 (18%) patients had ARID1A mutation. In grade III oligodendroglial tumors, an ARID1A mutation was associated with worse progression-free survival. Reclassification based on the WHO 2021 classification resulted in 62.5% of grade II/III isocitrate dehydrogenase (IDH)-wildtype astrocytomas be-ing classified as IDH-wildtype GBM and 37.5% as not elsewhere classified. In summary, our glioma-tailored gene panel was applicable for molecular diagnosis in the WHO 2021 classification. In addi-tion, we successfully reclassified the 303 diffuse glioma cases based on the WHO 2021 classification and clarified the genetic profile of diffuse gliomas in the Japanese population.

DOI： 10.2176/jns-nmc.2022-0103

Scopus

PubMed

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

記述言語：日本語   出版者・発行元：(株)メディカ出版  

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2022&ichushi_jid=J03120&link_issn=&doc_id=20220704260007&doc_link_id=issn%3D0917-1495%26volume%3D32%26issue%3D4%26spage%3D523&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0917-1495%26volume%3D32%26issue%3D4%26spage%3D523&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Neuro-Oncology Advances  

Background: Platelet-derived growth factor receptor alpha (PDGFRA) is the second most frequently mutated tyrosine kinase receptor in glioblastoma (GBM). However, the prognostic impact of PDGFRA amplification on GBM patients remains unclear. Herein, we evaluated this impact by retrospectively analyzing outcomes of patients with IDH wild-type GBM. Methods: Using a custom-made oncopanel, we evaluated PDGFRA gain/amplification in 107 GBM samples harboring wild-type IDH, along with MGMT promoter (MGMTp) methylation status. Results: We detected PDGFRA gain/amplification in 31 samples (29.0%). PDGFRA gain/amplification predicted poor prognosis (P =. 003). Compared to unamplified PDGFRA, PDGFRA gain/amplification in GBM was associated with higher patient age (P =. 031), higher Ki-67 score (P =. 019), and lower extent of surgical resection (P =. 033). Unmethylated MGMTp also predicted poor prognosis (P =. 005). As PDGFRA gain/amplification and unmethylated MGMTp were independent factors for poor prognosis in multivariate analyses, we grouped GBM cases based on PDGFRA and MGMTp status: poor (PDGFRA gain/amplification and unmethylated MGMTp), intermediate (PDGFRA gain/amplification or unmethylated MGMTp), and good (PDGFRA intact and methylated MGMTp) prognosis. The Kaplan-Meier survival analysis indicated that these groups significantly correlated with the OS of GBM patients (P <. 001). Conclusions: Here we report that PDGFRA gain/amplification is a predictor of poor prognosis in IDH wild-type GBM. Combining PDGFRA gain/amplification with MGMTp methylation status improves individual prognosis prediction in patients with IDH wild-type GBM.

DOI： 10.1093/noajnl/vdac097

Scopus

PubMed

その他リンク： https://academic.oup.com/noa/article-pdf/4/1/vdac097/45178840/vdac097.pdf

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Cancer Medicine  

Background: We aimed to evaluate the mutation profile, transcriptional variants, and prognostic impact of the epidermal growth factor receptor (EGFR) gene in isocitrate dehydrogenase (IDH)-wildtype glioblastomas (GBMs). Methods: We sequenced EGFR, evaluated the EGFR splicing profile using a next-generation sequencing oncopanel, and analyzed the outcomes in 138 grade IV IDH-wildtype GBM cases. Results: EGFR mutations were observed in 10% of GBMs. A total of 23.9% of the GBMs showed EGFR amplification. Moreover, 25% of the EGFR mutations occurred in the kinase domain. Notably, EGFR alterations were a predictor of good prognosis (p = 0.035). GBM with EGFR alterations was associated with higher Karnofsky Performance Scale scores (p = 0.014) and lower Ki-67 scores (p = 0.005) than GBM without EGFR alterations. EGFRvIII positivity was detected in 21% of EGFR-amplified GBMs. We identified two other EGFR variants in GBM cases with deletions of exons 6–7 (Δe 6–7) and exons 2–14 (Δe 2–14). In one case, the initial EGFRvIII mutation transformed into an EGFR Δe 2–14 mutation during recurrence. Conclusions: We found that the EGFR gene profiles of GBM differ among cohorts and that EGFR alterations are good prognostic markers of overall survival in patients with IDH-wildtype GBM. Additionally, we identified rare EGFR variants with longitudinal and temporal transformations of EGFRvIII.

DOI： 10.1002/cam4.4939

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Epilepsia Open  

Objective: The impact of the coronavirus disease 2019 (COVID-19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study. Methods: This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy center-specific monthly data divided by the 12-month average in 2019 for each facility. We determined whether the COVID-19 pandemic-related factors (such as year [2019 or 2020], COVID-19 cases in each prefecture in the previous month, and a state of emergency) were independently associated with these outcomes. Results: In 2020, the frequency of outpatient EEG studies (−10.7%, P <.001) and cases with telemedicine (+2608%, P =.031) were affected. The number of COVID-19 cases was an independent associated factor for epilepsy admission (−3.75 × 10−3% per case, P <.001) and EEG monitoring (−3.81 × 10−3% per case, P =.004). Furthermore, a state of emergency was an independent factor associated with outpatient with epilepsy (−11.9%, P <.001), outpatient EEG (−32.3%, P <.001), telemedicine for epilepsy (+12,915%, P <.001), epilepsy admissions (−35.3%; P <.001), EEG monitoring (−24.7%: P <.001), and epilepsy surgery (−50.3%, P <.001). Significance: We demonstrated the significant impact that the COVID-19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic-related factor on epilepsy care.

DOI： 10.1002/epi4.12616

Scopus

PubMed

記述言語：日本語   出版者・発行元：(一社)日本小児神経外科学会  

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Surgical Neurology International  

Background: We previously found the usefulness of dural sac shrinkage signs (DSSSs), which are the anterior shift of the spinal cord and dura mater behind the cord, detected by magnetic resonance imaging (MRI) at the thoracic level for the diagnosis of spontaneous intracranial hypotension (IH). This is a retrospective survey on the usefulness of DSSSs for the early detection of iatrogenic IH caused by overdrainage through a lumboperitoneal shunt (LPS) for patients with idiopathic normal pressure hydrocephalus (INPH). Methods: Forty-five INPH patients had an LPS using a pressure programmable valve equipped with an anti-siphon device. Results: Nine patients complained of orthostatic headache after the LPS, indicating IH due to overdrainage, which persisted for more than a week in three patients and 2-7days in six patients. The headache was transient/ nonorthostatic in ten patients and absent in 26 patients. The DSSSs and accompanying enlargement of the venous plexus were observed in all three patients with prolonged orthostatic headaches. Only the anterior shift of the dura mater was observed in 1 (4%) among 25 patients who had short-term orthostatic headache, transient/ nonorthostatic headache, or absent headache, and underwent spinal MRI. A patient with prolonged severe orthostatic headache with both DSSSs eventually developed intracranial subdural effusion and underwent tandem valve surgery, which provided a quick improvement of symptoms. The DSSSs on thoracic MRI also disappeared promptly. Conclusion: DSSSs may serve as objective signs for the diagnosis of IH due to overdrainage through an LPS for INPH.

DOI： 10.25259/SNI_291_2022

Scopus

PubMed

出版者・発行元：Scientific Reports  

DOI： 10.1038/s41598-021-84404-5

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：World Neurosurgery  

Objective: Pin-type head frame systems have become a worldwide standard procedure, but they can cause some complications on rare occasions. This study aimed to examine the incidence and associated risk factors of depressed skull fracture and related intracranial hematoma (DSFH) due to the use of head frames in our institute over the past 10 years. Methods: This study included 1749 patients who underwent neurosurgical surgeries using pin-type head frames, including the Mayfield (Integra NeuroSciences, Plainsboro, NJ) skull clamp (721 cases) and the Sugita (Mizuho Ikakogyo Co., Ltd., Tokyo, Japan) head frame (1028 cases). We retrospectively reviewed hospital records of our institute to identify cases of DSFH, and documented the type of head frame used, as well as patient characteristics. Results: The incidence of DSFH was 0.29% (5 of 1749 cases). All 5 cases had an associated epidural hematoma, with a single case having an additional dural laceration (without subdural damage). All perforation sites, located at the parietal bone near the pterion, occurred by the unilateral horizontal screw of the Sugita head frame. None of the patients experienced postoperative neurological decline. Conclusions: Even in the adult population, the DSFH by the pin-type head frame can occur infrequently. Based on our results, we recommend that the following factors should be considered when the pin-type head frame is used for neurosurgical procedures: location of pin application, thickness and fragility of the skull, and adequate control of compressive forces exerted by the head frame.

DOI： 10.1016/j.wneu.2021.08.070

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Acta Neurochirurgica  

Background: Spontaneous intracranial hypotension (SIH) is secondary to a cerebrospinal fluid leak at the spinal level without obvious causative events. Several signs on brain and cervical spine magnetic resonance (MR) imaging (MRI) have been associated with SIH but can be equivocal or negative. This retrospective study sought to identify characteristic SIH signs on thoracic spinal MRI. Methods: Cranial and spinal MR images of 27 consecutive patients with classic SIH symptoms, who eventually received epidural autologous blood patches (EBPs), were analyzed. Results: The most prevalent findings on T2-weighted MRI at the thoracic level were anterior shift of the spinal cord (96.3%) and dorsal dura mater (81.5%), probably caused by dural sac shrinkage. These dural sac shrinkage signs (DSSS) were frequently accompanied by cerebrospinal fluid collection in the posterior epidural space (77.8%) and a prominent epidural venous plexus (77.8%). These findings disappeared in all six patients who underwent post-EBP spinal MRI. Dural enhancement and brain sagging were minimum or absent on the cranial MR images of seven patients, although DSSS were obvious in these seven patients. For 23 patients with SIH and 28 healthy volunteers, a diagnostic test using thoracic MRI was performed by 13 experts to validate the usefulness of DSSS. The median sensitivity, specificity, positive-predictive value, negative-predictive value, and accuracy of the DSSS were high (range, 0.913–0.931). Conclusions: Detection of DSSS on thoracic MRI facilitates an SIH diagnosis without the use of invasive imaging modalities. The DSSS were positive even in patients in whom classic cranial MRI signs for SIH were equivocal or minimal.

DOI： 10.1007/s00701-021-04933-w

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Neurosurgery  

BACKGROUND: Microvascular decompression (MVD) is the most effective procedure for the long-term management of trigeminal neuralgia (TGN). However, retrospective and single-center studies are inherently biased, and there are currently no prospective, multicenter studies. OBJECTIVE: To evaluate the short- and long-term outcomes and complications in patients with TGN who underwent MVD at specialized Japanese institutions. METHODS: We enrolled patients with TGN who underwent MVD between April 2012 and March 2015. We recorded their facial pain grade and complications at 7 d (short term), 1 yr (mid-term), and 3 yr (long term) postoperatively. RESULTS: There were 166 patients, comprising 60 men and 106 women (mean age 62.7 yr). Furthermore, 105 patients were aged over 60 yr. We conducted neuromonitoring in 84.3% of the cases. The complete pain relief, mortality, and complication rates at the short-term follow-up were 78.9%, 0%, and 16.3%, respectively. Overall, 155 patients (93.4%) completed the long-term follow-up, with the complete pain relief and complication rates of 80.0% and 5.2%, respectively. CONCLUSION: In the hands of experienced neurosurgeons, MVD for TGN can achieve high long-term curative effects. In addition, complications are uncommon and usually transient. Our results indicate that MVD is an effective and safe treatment for patients with TGN, including elderly patients.

DOI： 10.1093/neuros/nyab229

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Interdisciplinary Neurosurgery: Advanced Techniques and Case Management  

Objective: Various clinical parameters have been reported to be associated with favorable seizure outcomes after vagus nerve stimulation (VNS); however, none of these parameters have been conclusively validated. Here, we evaluated interpersonal communication skills (IPCS) and seizure outcomes in pediatric patients treated with VNS. Methods: We enrolled 31 Japanese pediatric patients (mean ± SD: 9.0 ± 3.4 years old, range: 3–15 years old) who were treated with VNS and had at least 2 years of follow-up. We divided the patients into two groups: a responder group with ≥50% seizure reduction from the average number of seizures 2 months before VNS; and a nonresponder group with <50% seizure reduction. We assessed the clinical parameters for predicting responders after VNS, including the etiology of epilepsy, seizure characteristics, EEG and MRI findings, medications, the intelligence quotient and/or developmental quotient, and interpersonal communication skills (IPCS) between the two groups. We classified IPCS as the ability of patients to use at least simple-word communication in Japanese. Results: We found significantly favorable seizure outcomes (≥50% seizure reduction) in 12 of 19 (63.2%) patients with IPCS after 2-year VNS compared with one of 12 (8.3%) patients without ICPS (p = 0.0031, Fisher exact test). IPCS showed an odds ratio of 14.6 (95% CI, 1.9–318) and a significant correlation with a favorable seizure outcome (p = 0.0077) in binominal logistic regression analysis. Conclusion: Feasible evaluation of IPCS by clinicians might predict the seizure outcome more than 2 years after VNS implantation in a pediatric population.

DOI： 10.1016/j.inat.2020.101080

Scopus

記述言語：日本語   出版者・発行元：株式会社医学書院  

DOI： 10.11477/mf.1436204439

PubMed

出版者・発行元：Neurosurgery  

DOI： 10.1093/neuros/nyaa549

Scopus

PubMed

記述言語：英語   出版者・発行元：一般社団法人 日本脳神経外科学会  

<p>Seizure clusters (SCs) are acute repetitive seizures with acute episodes of deterioration during seizure control. SCs can be defined as a series of grouped seizures with short interictal periods. Vagus nerve stimulation (VNS) is a treatment option for drug-resistant epilepsy. We present a case where VNS suppressed epileptic SCs, which had persisted for several months. A 13-year-old boy with congenital cerebral palsy and mental retardation had drug-resistant epilepsy with daily jerking movements and spasms in both sides of his body. The seizures were often clustered, and he experienced two sustained SC episodes that persisted for a few months even with prolonged use of continuous intravenous midazolam (IV-MDZ). The patient underwent VNS device placement at the second sustained SC and rapid induction of VNS. Because the tapering of IV-MDZ did not exacerbate the SC, midazolam was discontinued 4 weeks after VNS initiation. Non-refractory SCs also disappeared 10 months after VNS. The seizure severity was improved, and the frequency of seizures reduced from daily to once every few months. The epileptic activity on electroencephalography (EEG) significantly decreased. This case highlights VNS as an additional treatment option for SC. VNS may be a therapeutic option if SC resists the drugs and sustains. Additional studies are necessary to confirm our findings and to investigate how device implantation and stimulation parameters affect the efficacy of VNS.</p>

DOI： 10.2176/nmccrj.cr.2020-0137

PubMed

記述言語：英語   出版者・発行元：一般社団法人 日本脳神経外科学会  

<p>Behçet's disease (BD) is a rare chronic inflammatory disease associated with systemic vasculitis. Involvement of the nervous system in BD is called neuro-BD (NBD). Epilepsy related to NBD is uncommon but responds well to anti-epileptic drugs. We present a case of NBD with drug-resistant mesial temporal lobe epilepsy (MTLE) due to hippocampal sclerosis (HS). The patient presented with headache, dizziness, disorientation, and generalized seizures. Magnetic resonance imaging (MRI) identified pontine lesions. Chronic inflammation was suspected, and steroid pulse therapy improved his symptoms. He relapsed 1 year after onset and was diagnosed with NBD. MRI revealed bilateral mesial temporal lesions, with the right being edematous and the left atrophic. NBD was controlled by steroid and immunosuppressive medication. Three years after the onset of NBD, the patient suffered MTLE, and MRI suggested left hippocampal atrophy. His seizures became drug-resistant and surgical therapy was considered 12 years after NBD onset. Pre-surgical MRI clearly showed left HS. After evaluations, the patient had left anterior temporal lobectomy (ATL) 13 years after NBD onset under stable NBD. The patient was seizure-free for > 2 years after surgery. Surgery will be an effective treatment for drug-resistant MTLE with HS even in patients with NBD, of course the effects of surgical intervention should be considered.</p>

DOI： 10.2176/nmccrj.cr.2020-0218

PubMed

出版者・発行元：Scientific Reports  

DOI： 10.1038/s41598-020-64968-4

Scopus

PubMed

出版者・発行元：Epilepsy and Behavior  

DOI： 10.1016/j.yebeh.2020.107255

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

出版者・発行元：広島大学医学出版会  

症例は56歳女性で、構音障害を主訴とし、拡散強調画像(DWI)により、右前頭葉病変周囲に高強度領域が描出された。虚血性脳血管障害として治療を行ったところ、3日で症状の鎮静が得られたが、7日後のMRI検査で高強度領域の拡大が観察された。また、ガドリニウム(Gd)造影MRIでは、延髄細静脈に異常に大きな静脈が描出され、髄液中β2-ミクログロブリン(β2MG)濃度は2061μg/ lにまで上昇した。悪性腫瘍との鑑別を要したが、術後23日目のMRIにより、病変部の完全消失とDWI上での高輝度領域減少が認められたことから、本例に観察された発生学的静脈形成異常(DVA)は灌流障害による症候性と判断された。

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

DOI： 10.4103/ajns.AJNS_266_17

PubMed

出版者・発行元：Epilepsy and Behavior Reports  

DOI： 10.1016/j.ebr.2019.100337

Scopus

PubMed

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

出版者・発行元：Epilepsia Open  

DOI： 10.1002/epi4.12260

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

出版者・発行元：Acta Neurochirurgica  

DOI： 10.1007/s00701-017-3336-4

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

出版者・発行元：Neuroradiology Journal  

DOI： 10.1177/1971400916678228

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

出版者・発行元：一般社団法人 日本脳神経外科学会  

<p>Given the anatomical proximity of tuberculum sellae meningioma (TSM) to the hypothalamo-pituitary system, pituitary function impairments are of great concern. We retrospectively investigated pituitary function changes following surgery in patients with TSM using pituitary provocation tests (PPTs). Thirty-one patients (27 females and 4 males) with TSM underwent initial transcranial surgery (29 patients) or transsphenoidal surgery (two patients); surgeries were performed carefully to avoid injuring the pituitary stalk. In 24 patients, the PPTs were performed via a triple bolus injection with regular insulin, thyrotropin-releasing hormone (TRH), and luteinizing hormone releasing hormone (LH-RH). Seven patients underwent a quadruple test (growth-hormone-releasing factor, corticotrophin-releasing hormone, TRH, and LH-RH). The preoperative and postoperative target hormone levels of the anterior pituitary were normal in 93.5% and 96.8% of patients, respectively. At least one hormonal axis demonstrated impaired PPT responses in two patients (6.5%) preoperatively and in one patient (3.2%) postoperatively. The growth hormone (GH) response was also well preserved. A compromised GH peak level was only observed in one patient (3.2%) preoperatively. Postoperatively, transient diabetes insipidus and transient hyponatremia were observed in four (12.9%) and eight (25.8%) patients, respectively. No patients needed permanent postoperative hormone replacement. The preoperative pituitary function was well preserved in most patients, including those with large tumors pushing against the pituitary stalk considerably or embedded in it. After careful surgery to avoid damaging the pituitary stalk, pituitary function was preserved. However, transient postoperative hyponatremia occurred in 25.8% of patients; thus, surgeons should pay careful attention to this issue.</p>

DOI： 10.2176/nmc.oa.2017-0079

Scopus

PubMed

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（研究会，シンポジウム資料等）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（その他学術会議資料等）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

Scopus

担当区分：筆頭著者   記述言語：日本語   掲載種別：研究論文（学術雑誌）  

担当区分：筆頭著者   記述言語：英語   掲載種別：研究論文（学術雑誌）  

記述言語：日本語   掲載種別：研究論文（学術雑誌）  

Scopus

担当ページ：185-194   記述言語：英語

記述言語：日本語   出版者・発行元：(株)医学書院  

＜文献概要＞Point　・視床下部と下垂体は,ホルモンを介した綿密な連携で生体の恒常性維持に重要な役割を担っている.・ホルモンデータを解釈する際は,検査値に影響を与える因子を理解しておく必要がある.

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(株)医学書院  

＜文献概要＞Point ・適切な薬物治療によって60～70%の患者で発作が消失する.・抗てんかん薬の服用はしばしば長期に及ぶため,発作型だけではなく,副作用を含めた各薬剤の特性と患者のライフサイクルを念頭に置いた薬剤選択を行う.・新規抗てんかん薬は,従来薬に比べて薬物相互作用や長期内服に伴う副作用が軽減している.

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2023&ichushi_jid=J01228&link_issn=&doc_id=20230130160014&doc_link_id=10.11477%2Fmf.1436204720&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1436204720&type=%E5%8C%BB%E6%9B%B8.jp_%E3%82%AA%E3%83%BC%E3%83%AB%E3%82%A2%E3%82%AF%E3%82%BB%E3%82%B9&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

脳梁離断術はてんかん性スパズム、強直発作、脱力発作などの転倒する発作で最も有効とされる。今回、非定型欠神発作重積に脳梁離断術が有効だった1例を経験したので報告する。症例は6歳女児。生後Down症候群と診断された。8ヵ月時にWest症候群を発症した。5歳時から強直発作、ミオクロニー発作、非定型欠神発作などの多彩な発作を認めるようになり、Lennox-Gastaut syndrome spectrumと診断した。6歳0ヵ月時には最大で1日100回以上の非定型欠神発作が出現して、脳波検査では発作時、発作間欠時脳波ともに全般性変化を呈した。難治に経過し、薬剤治療による欠神発作重積の抑制は困難と判断して6歳1ヵ月時に脳梁離断術を行った。手術直後から各種発作は消失した。術後の脳波では全般性棘徐波が右前頭部に局在化した。脳梁を介した神経興奮の拡がりが脳梁離断術によって抑制されたことによって、全般発作である非定型欠神発作が抑えられた可能性を考えた。本症例の経験から、特に欠神発作重積が薬剤抵抗性で退行を呈するなどの緊急性を要する症例では、脳梁離断術の適応を積極的に検討すべきと考えた。(著者抄録)

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2023&ichushi_jid=J01742&link_issn=&doc_id=20230214200003&doc_link_id=10.3805%2Fjjes.40.541&url=https%3A%2F%2Fdoi.org%2F10.3805%2Fjjes.40.541&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_2.gif

記述言語：日本語   出版者・発行元：(一社)日本定位・機能神経外科学会  

記述言語：日本語   出版者・発行元：(株)医学書院  

＜文献概要＞Point　・適切な薬物治療によって60～70%の患者で発作が消失する.・抗てんかん薬の服用はしばしば長期に及ぶため,発作型だけではなく,副作用を含めた各薬剤の特性と患者のライフサイクルを念頭に置いた薬剤選択を行う.・新規抗てんかん薬は,従来薬に比べて薬物相互作用や長期内服に伴う副作用が軽減している.

記述言語：日本語   出版者・発行元：(有)科学評論社  

記述言語：日本語   出版者・発行元：(NPO)日本脳神経血管内治療学会  

記述言語：日本語   出版者・発行元：(NPO)日本脳神経血管内治療学会  

記述言語：日本語   出版者・発行元：(一社)日本頭痛学会  

記述言語：日本語   出版者・発行元：(NPO)日本脳神経血管内治療学会  

記述言語：日本語   出版者・発行元：(NPO)日本脳神経血管内治療学会  

記述言語：日本語   出版者・発行元：(有)科学評論社  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：英語   出版者・発行元：(一社)日本癌学会  

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

記述言語：日本語   出版者・発行元：(一社)日本てんかん学会  

記述言語：日本語   出版者・発行元：(一社)日本内分泌学会  

50歳代男性。頭痛の精査目的に施行された頭部MRIで鞍上部腫瘍を認められ、当科に紹介された。MRI所見は鞍上部に最大径17mmの腫瘍性病変を認め、腫瘍は視路に接していた。内分泌学的には明らかな異常は認めず、視野検査でも明らかな障害は認めなかった。無症候性ではあるものの、腫瘍が視路に接しており将来的には症候性となることが予想されたことなどから早期の手術介入の方針とし、開頭経鼻同時手術を施行した。腫瘍は赤色調で周囲脳や硬膜との癒着は目立たなかったが、右の視神経との癒着が強固であった。術中所見から右海綿静脈洞内への腫瘍進展が疑われたため、同部位と視神経周囲は愛護的に操作して腫瘍を摘出し、病理組織所見から傍神経節腫と診断した。術後に全身検索を行い、中枢神経単発の非機能性傍神経節腫と最終診断した。右海綿静脈洞周囲の残存腫瘍が緩徐に増大し、摘出術から17ヵ月後にガンマナイフ照射を行った。

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2022&ichushi_jid=J01160&link_issn=&doc_id=20220817460019&doc_link_id=10.1507%2Fendocrine.98.S.HPT_63&url=https%3A%2F%2Fdoi.org%2F10.1507%2Fendocrine.98.S.HPT_63&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

記述言語：日本語   出版者・発行元：(株)メディカ出版  

記述言語：日本語   出版者・発行元：(株)メディカ出版  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：日本脳腫瘍病理学会  

記述言語：日本語   出版者・発行元：(株)中外医学社  

記述言語：日本語   出版者・発行元：(一社)日本小児神経外科学会  

記述言語：日本語   出版者・発行元：(一社)日本定位・機能神経外科学会  

J-GLOBAL

J-GLOBAL

J-GLOBAL

記述言語：日本語   出版者・発行元：(株)医学書院  

＜文献概要＞Point　・臓器機能や認知機能の低下に対して高齢者総合機能評価(CGA)を行い,治療強度を適切に調整する.・脆弱(unfit)の高齢者患者に対して寡分割放射線照射やテモゾロミド単独療法などが開発され,非劣性が示された.・高齢者グリオーマに対するてんかん治療では,臓器機能や認知機能と薬物代謝に配慮が必要である.

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

出版者・発行元：(一社)日本てんかん学会  

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

J-GLOBAL

出版者・発行元：(株)メディカルレビュー社  

出版者・発行元：(一社)日本てんかん学会  

シナプス小胞糖タンパク2A(synaptic vesicle glycoprotein 2A:SV2A)は、シナプス小胞に特異的に発現する膜タンパクで、即時放出可能プールのシナプス前膜への融合、プライミング、synaptotagmin-1との相互作用などの、エキソサイトーシス機構を調節することにより、神経伝達物質の放出を制御すると考えられている。抗てんかん薬レベチラセタム(LEV)がSV2Aに結合することが発見されて以来、SV2Aとてんかん発現との関連が注目されてきた。疾患モデルやヒトでのてんかん研究ではSV2A発現が低下するとの報告が多く、てんかんの発現には抑制系のSV2Aが関連していることが推測される。一方で、LEVの作用機序に関する報告は、LEVが興奮系のSV2Aを介して作用することを示唆する。SV2Aは興奮性と抑制性シナプスの両方に存在し、また実験系や背景疾患などによってSV2A発現に相違があるため、その役割を現時点で明確に特定することは難しい。SV2Aの生理的機構や関連する病態の解明に向けて研究の発展が望まれる。(著者抄録)

出版者・発行元：(株)メディカ出版  

記述言語：日本語   掲載種別：記事・総説・解説・論説等（学術雑誌）  

開催年月日： 2012年9月

記述言語：日本語  

開催地：横浜  

国内学会

開催年月日： 2012年7月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2012年6月

記述言語：日本語  

開催地：大分  

国内学会

開催年月日： 2012年1月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2012年1月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2011年10月

記述言語：日本語  

開催地：横浜  

国内学会

開催年月日： 2011年10月

記述言語：日本語  

開催地：新潟  

国内学会

開催年月日： 2011年9月

記述言語：日本語  

開催地：横浜  

国内学会

開催年月日： 2010年8月

記述言語：英語  

開催地：インドネシア  

国際学会

開催年月日： 2010年8月

記述言語：英語  

開催地：インドネシア  

国際学会

開催年月日： 2010年4月

記述言語：英語  

開催地：鹿児島  

国際学会

開催年月日： 2010年3月

記述言語：日本語  

開催地：鹿児島  

国内学会

開催年月日： 2010年1月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2009年10月

記述言語：日本語  

開催地：弘前  

国内学会

開催年月日： 2009年10月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2009年9月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2009年8月

記述言語：英語  

開催地：アメリカ合衆国  

国際学会

開催年月日： 2009年8月

記述言語：英語  

開催地：アメリカ合衆国  

国際学会

開催年月日： 2009年8月

記述言語：英語  

開催地：アメリカ合衆国  

国際学会

開催年月日： 2009年7月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2009年6月

記述言語：英語  

開催地：Osaka  

国際学会

開催年月日： 2009年6月

記述言語：日本語  

開催地：久留米  

国内学会

開催年月日： 2009年5月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2009年3月

記述言語：日本語  

開催地：広島  

国内学会

開催年月日： 2009年3月

記述言語：日本語  

開催地：広島  

国内学会

開催年月日： 2009年2月

記述言語：日本語  

開催地：福岡  

研究会

開催年月日： 2008年12月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2008年10月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2008年10月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2008年7月

記述言語：日本語  

開催地：鹿児島  

その他

開催年月日： 2008年7月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2008年7月

記述言語：日本語  

開催地：鹿児島  

研究会

開催年月日： 2008年6月

記述言語：日本語  

開催地：福岡  

国内学会

開催年月日： 2008年1月

記述言語：日本語  

開催地：東京  

国内学会

開催年月日： 2007年12月

記述言語：英語  

開催地：アメリカ合衆国  

国際学会

開催年月日： 2007年11月

記述言語：日本語  

開催地：福岡  

国内学会

開催年月日： 2006年9月

記述言語：日本語  

開催地：石川  

国内学会

開催年月日： 2006年3月

記述言語：日本語  

開催地：神奈川  

国内学会

開催年月日： 2005年10月

記述言語：日本語  

開催地：北海道  

国内学会

開催年月日： 2005年8月

記述言語：英語  

開催地：フランス  

国際学会

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：英語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：英語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：英語  

記述言語：英語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：英語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語  

記述言語：日本語